Sign up to save your podcasts
Or
Share SPECIAL REPORT on Aducanumab Approval: Steve Pearson of ICER Discusses the Economic and Clinical Impact
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
SPECIAL REPORT on Aducanumab Approval: Steve Pearson of ICER Discusses the Economic and Clinical Impact
Dr. Jason Crowell speaks with Dr. Steve Pearson, President of the Institute for Clinical and Economic Review, about the clinical and economic impact of aducanumab, a drug recently approved by the FDA for the treatment of Alzheimer disease.
View all episodes
By American Academy of Neurology
4.7
285285 ratings
Dr. Jason Crowell speaks with Dr. Steve Pearson, President of the Institute for Clinical and Economic Review, about the clinical and economic impact of aducanumab, a drug recently approved by the FDA for the treatment of Alzheimer disease.
More shows like Neurology® Podcast
View all
NEJM This Week
318 Listeners
JAMA Clinical Reviews
498 Listeners
Practical Neurology Podcast
51 Listeners
The Curbsiders Internal Medicine Podcast
3,341 Listeners
JAMA Neurology Author Interviews
12 Listeners
Core IM | Internal Medicine Podcast
1,149 Listeners
Neurology Today in 5
23 Listeners
Annals On Call Podcast
193 Listeners
The Clinical Problem Solvers
512 Listeners
Neurology Minute
134 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Neurology Exam Prep Podcast
190 Listeners
The Curious Clinicians
370 Listeners
Ninja Nerd
318 Listeners
Continuum Audio
81 Listeners